Certainly, AIT offers a diverse range of dosage forms for its pharmaceutical products, providing flexibility and convenience for patients and healthcare providers. Some of the common dosage forms available include:
-
- Tablets: Solid oral dosage forms containing active pharmaceutical ingredients (APIs) compressed into flat, round, or oblong shapes for oral administration. Tablets may be immediate-release, extended-release, or chewable, catering to different patient preferences and therapeutic needs.
- Capsules: Gelatin or vegetarian shells filled with powdered or granular APIs, typically used for oral administration. Capsules offer precise dosing, easy swallowing, and may be formulated as immediate-release, delayed-release, or sustained-release formulations.
- Oral Solutions/Syrups: Liquid formulations containing APIs dissolved or suspended in a flavored aqueous base, designed for oral ingestion using a measuring device or spoon. Oral solutions are commonly used for pediatric or geriatric patients who have difficulty swallowing solid dosage forms.
- Injections: Parenteral dosage forms administered via intravenous (IV), intramuscular (IM), or subcutaneous (SC) routes, delivering APIs directly into the bloodstream or muscle tissue for rapid onset of action. Injectable formulations include solutions, suspensions, or emulsions, ensuring accurate dosing and high bioavailability.
- Topical Creams/Ointments: Semi-solid dosage forms applied to the skin or mucous membranes for local or transdermal drug delivery. Creams contain water and oil phases, providing moisturizing properties and easy spreadability, while ointments are hydrophobic formulations with occlusive properties for enhanced drug absorption and retention.
- Eye Drops/Ointments: Sterile formulations administered directly into the eye for the treatment of ocular conditions such as infections, inflammation, or glaucoma. Eye drops deliver precise dosing and rapid onset of action, while ointments provide prolonged contact time and lubrication for dry eyes.
- Inhalers/Nebulizers: Metered-dose inhalers (MDIs), dry powder inhalers (DPIs), or nebulizer solutions used for pulmonary drug delivery to treat respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. Inhalation devices deliver APIs directly to the lungs for optimal therapeutic effect and minimal systemic side effects.
- Suppositories: Solid dosage forms inserted into the rectum or vagina for local or systemic drug absorption. Suppositories melt or dissolve at body temperature, releasing the API for rapid or sustained drug delivery, suitable for patients unable to take medications orally.
- Powders/Sachets: Dry formulations containing finely divided APIs for reconstitution in water or another suitable solvent before administration. Powders/sachets offer convenient dosing, stability, and ease of transportation, ideal for pediatric or geriatric patients and travel-friendly packaging.
- Drops/Sprays: Liquid formulations dispensed as droplets or sprays for nasal, otic (ear), or oropharyngeal (throat) administration. Drops/sprays provide localized drug delivery, relieving symptoms of nasal congestion, allergies, or sore throat, with precise dosing and rapid onset of action.
These varied dosage forms reflect AIT’s commitment to meeting patient needs and preferences while ensuring effective drug delivery, therapeutic efficacy, and safety across different routes of administration.
